CLINICAL ROLE -
Novel Hepatitis B Drug May Improve Long-Term Treatment
Phase 3 study results show high efficacy and improved renal and bone safety parameters with tenofovir alafenamide regimen.
Read More
Broadly Neutralizing Antibodies May Reduce HIV Levels
Researchers achieve promising first step in new HIV treatment approach.
FDA Grants Priority Review to HCV Combination Therapy
Sofosbuvir and velpastavir combination being evaluated for hepatitis C genotypes 1-6.
Palbociclib May Prove Effective Across Variety of Cancer Drugs
Palbociclib has been found effective inhibiting the mobilization of enzymes that contribute to the rapid division of tumor cells.